Alphyn Biologics
Clinical-stage dermatology co. developing first-in-class Multi-Target Therapeutics (MTT)
Based in MD
🤖
AI Overview
With $30K in lobbying spend across 3 quarterly filings, Alphyn Biologics is an active lobbying client. Their lobbying covers 2 issue areas.
$30K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED
- •Issues related to the development of biologic therapies before Congress, the Food and Drug Administration (FDA), and other federal health agencies.
- •Advocacy work around Atopic Dermatitis (eczema).
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.